MyndTec Inc. Announces Board Resignation of P. Harvey Griggs

An announcement from MyndTec, Inc. ( (TSE:MYTC) ) is now available.

MyndTec Inc. announced the resignation of P. Harvey Griggs from its Board of Directors, effective November 26, 2025, due to personal health reasons. Dr. Griggs, an early investor and six-year director, was praised for his contributions to the company’s mission to enhance rehabilitation outcomes for stroke and spinal cord injury patients. The company has decided not to fill the vacancy at this time, which may impact its strategic direction and governance.

Spark’s Take on TSE:MYTC Stock

According to Spark, TipRanks’ AI Analyst, TSE:MYTC is a Underperform.

MyndTec, Inc. faces significant financial challenges, with substantial risks due to negative equity and persistent losses, which weigh heavily on its overall score. Despite some positive momentum from a recent private placement initiative, the technical indicators suggest a bearish trend, and the absence of key valuation metrics further limits investor appeal. Collectively, these factors contribute to a low overall score, indicating caution for potential investors.

To see Spark’s full report on TSE:MYTC stock, click here.

More about MyndTec, Inc.

MyndTec Inc. is a medical technology company listed on the CSE, specializing in neurological treatment and rehabilitation. The company focuses on using neurostimulation to restore function and improve treatment for individuals with central nervous system disorders, such as Parkinson’s disease, Alzheimer’s disease, and stroke. Their flagship product, the MyndMove™ system, is a non-invasive intervention that aids in developing new neural pathways to help patients regain voluntary movement and independence.

Average Trading Volume: 7,400

Technical Sentiment Signal: Sell

For an in-depth examination of MYTC stock, go to TipRanks’ Overview page.